Back

Effects of immunosuppressive therapy on the clinical outcomes in patients with cardiac sarcoidosis

31 March 2025 (08:25 - 09:15)
Organised by: Logo
Congress Presentation Part of: Arrhythmias and clinical care Cardiac Diseases EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Hans Ebbinghaus

Heart Center of Leipzig, Leipzig (Germany)

4 More presentations in this session

Presentation thumbnail
Is there an association between device-detected atrial fibrillation and diabetes? A propensity score-matched analysis from the Italian Home Monitoring Expert Alliance project
Doctor G. Malanchini (Bergamo, IT)
Abstract Slides Video
Presentation thumbnail
Prediction of atrial fibrillation in patients without heart failure: validation study in 3.3 million individuals
Doctor H. Ismail (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
A virtual atrial fibrillation clinic after pulmonary vein isolation: lessons learned from 1000 patient-years.
Doctor J. Balt (Nieuwegein, NL)
Abstract Slides Video
Presentation thumbnail
Analysis of physical activity and sleep behaviour preceding malignant ventricular arrhythmias treated by implanted cardioverter-defibrillators
Mrs F. Raijmakers (Amsterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmias and clinical care

The Event

Event poster

EHRA 2025

31 March 2025 08:25 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac Sarcoidosis treated with non-steroidal immunosuppressive therapy
thumbnail
Congress Presentation
Cardiac sarcoidosis
thumbnail
Congress Presentation
Challenges in arrhythmia management in cardiac sarcoidosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources